LTP impairment by fractalkine/CX3CL1 in mouse hippocampus is mediated through the activity of adenosine receptor type 3 (A3R)

Laura Maggi, Flavia Trettel, Maria Scianni, Cristina Bertollini, Fabrizio Eusebi, Bertil B. Fredholm, Cristina Limatola

Research output: Contribution to journalArticle

Abstract

We have examined how the chemokine fractalkine/CX3CL1 influences long-term potentiation (LTP) in CA1 mouse hippocampal slices. Field potentials (fEPSPs) were recorded upon electrical stimulation of Schaffer collaterals. It was found that application of CX3CL1 inhibits LTP when present during the critical induction period. LTP impairment (i) failed to occur in CX3CR1 deficient mice (CX3CR1GFP/GFP) and in the presence of okadaic acid (OA); (ii) required the activation of adenosine receptor 3 (A3R), since it was prevented in A3R-deficient mice or by MRS1523, a selective A3R antagonist. Together, these findings indicate that CX3CL1 inhibits hippocampal LTP through A3R activity.

Original languageEnglish
Pages (from-to)36-42
Number of pages7
JournalJournal of Neuroimmunology
Volume215
Issue number1-2
DOIs
Publication statusPublished - Oct 30 2009

Keywords

  • Adenosine receptor
  • Chemokine
  • fEPSP
  • Glutamate receptor
  • Hippocampus
  • LTP

ASJC Scopus subject areas

  • Immunology
  • Clinical Neurology
  • Immunology and Allergy
  • Neurology

Fingerprint Dive into the research topics of 'LTP impairment by fractalkine/CX3CL1 in mouse hippocampus is mediated through the activity of adenosine receptor type 3 (A3R)'. Together they form a unique fingerprint.

  • Cite this